| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 160.778 | 159.282 | 155.451 | 162.158 | 146.259 | 188.201 | 175.378 | 181.614 | 196.913 | 196.641 |
| Total Income - EUR | 166.293 | 165.055 | 160.016 | 166.929 | 150.198 | 193.801 | 179.418 | 185.093 | 198.443 | 197.931 |
| Total Expenses - EUR | 160.678 | 157.534 | 155.055 | 161.911 | 146.016 | 178.970 | 167.539 | 174.511 | 187.011 | 188.349 |
| Gross Profit/Loss - EUR | 5.615 | 7.521 | 4.961 | 5.018 | 4.182 | 14.830 | 11.879 | 10.582 | 11.432 | 9.581 |
| Net Profit/Loss - EUR | 4.584 | 6.202 | 3.495 | 3.349 | 2.680 | 12.892 | 10.085 | 8.731 | 9.448 | 7.974 |
| Employees | 3 | 3 | 0 | 3 | 3 | 3 | 3 | 0 | 0 | 2 |
Check the financial reports for the company - Sanofarm L.g. Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 57.016 | 50.035 | 46.610 | 50.475 | 47.783 | 62.719 | 54.064 | 60.714 | 51.735 | 50.310 |
| Inventories | 31.119 | 27.981 | 26.788 | 20.112 | 24.214 | 29.022 | 30.610 | 31.631 | 27.205 | 29.467 |
| Receivables | 22.515 | 9.330 | 14.654 | 25.128 | 21.866 | 27.788 | 22.211 | 21.186 | 20.035 | 17.365 |
| Cash | 3.382 | 12.724 | 5.168 | 5.234 | 1.704 | 5.910 | 1.243 | 7.896 | 4.495 | 3.479 |
| Shareholders Funds | 4.719 | 6.335 | 3.626 | 3.477 | 2.806 | 13.016 | 10.206 | 8.852 | 9.569 | 8.094 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 52.345 | 43.700 | 42.985 | 46.998 | 44.977 | 49.703 | 43.858 | 51.862 | 42.166 | 42.216 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Sanofarm L.g. Srl